Human reporter gene assays: Transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context

Toxicology

Volumn 220, Issue 2-3, 2006, Pages 90-103

  Simon, Stephanie ^a   Mueller, Stefan O ^a  

^a MERCK KGAA   (Germany)

Author keywords

22Rv1; Androgen response elements; Androgens; HepG2; Human androgen receptor; LNCaP; Xenohormones

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CYPROTERONE ACETATE; ESTRADIOL; FLUTAMIDE; LINURON; METRIBOLONE; PROBASIN; SECRETORY COMPONENT; TESTOSTERONE; VINCLOZOLIN; XENOBIOTIC AGENT;

ANDROGEN RESPONSE ELEMENT; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENDOCRINE FUNCTION; GENETIC TRANSCRIPTION; GLUCOCORTICOID CONSENSUS RESPONSE ELEMENT; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL ASSAY; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; GENE EXPRESSION; GENES, REPORTER; HUMANS; LIGANDS; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, ANDROGEN; TESTOSTERONE; TRANSFECTION; XENOBIOTICS;

MOUSE MAMMARY TUMOR VIRUS;

EID: 33244486574     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.12.002     Document Type: Article

References (48)

1. T.K. Archer, E. Zaniewski, M.L. Moyer, and S.K. Nordeen The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells Mol. Endocrinol. 8 1994 1154 1162
2. B.J. Attardi, J. Burgenson, S.A. Hild, and J.R. Reel Steroid hormonal regulation of growth, prostate specific antigen secretion and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells Mol. Cell. Endocrinol. 222 2004 21 132
3. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.E., Seidman, J.G., Smith, J.A., Struhl, K., 1998. Curr. Prot. Mol. Biol. John Wiley and Sons, New York.
4. J. Bektic, A.P. Berger, K. Pfeil, G. Dobler, G. Bartsch, and H. Klocker Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta Eur. Urol. 45 2004 245 251
5. C.A. Berrevoets, A. Umar, and A.O. Brinkmann Antiandrogens: selective androgen receptor modulators Mol. Cell Endocrinol. 198 2002 97 103
6. C. Chang, J.M. Kokontis, and S.T. Liao Molecular cloning of human and rat complementary DNA encoding androgen receptors Science 240 1988 324 326
7. Z. Culig, G. Bartsch, and A. Hobisch Antiandrogens in prostate cancer endocrine therapy Curr. Cancer Drug Targets 4 2004 455 461
8. J.P. Elo, L.P. Kvist, K. Leinonen, V. Isoma, P.M. Henttu, O. Lukkarinen, and P. Vihko Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol J. Clin. Endocrinol. Metab. 80 1995 3494 3500
9. S. Gao, G.-Z. Liu, and Z. Wang Modulation of androgen receptor-dependent transcroption by resveratrol and genistein in prostate cancer cells Prostate 59 2004 214 225
10. C.K. Glass, D.W. Rose, and M.G. Rosenfeld Nuclear receptor coactivators Curr. Opin. Cell Biol. 9 1997 222 232
11. L.E. Gray Jr. Xenoendocrine disrupters: laboratory studies on male reproductive effects Toxicol. Lett. 102-103 1998 331 335
12. L.E. Gray, J. Ostby, J. Furr, C.J. Wolf, C. Lambright, L. Parks, D.N. Veeramachaneni, V. Wilson, M. Price, A. Hotchkiss, E. Orlando, and L. Guillette Effects of environmental antiandrogens on reproductive development in experimental animals Hum. Reprod. Update 7 2001 248 264
13. A. Haelens, G. Verrijdt, E. Schoenmakers, P. Alen, B. Peeters, W. Rombauts, and F. Claessens The first exon of the human sc gene contains an androgen responsive unit and an interferon regulatory factor element Mol. Cell Endocrinol. 153 1999 91 102
14. A. Hartel, A. Didier, M.W. Pfaffl, and H.H. Meyer Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds J. Steroid Biochem. Mol. Biol. 84 2003 231 238
15. P.C. Hartig, K.L. Bobseine, B.H. Britt, M.C. Cardon, C.R. Lambright, V.S. Wilson, and L.E. Gray Jr. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening Toxicol. Sci. 66 2002 82 90
16. C.A. Heinlein, and C. Chang The roles of androgen receptors and androgen-binding proteins in non-genomic androgen actions Mol. Endocrinol. 16 2002 2181 2187
17. L.E. Heisler, A. Evangelou, A.M. Lew, J. Trachtenberg, H.P. Elsholtz, and T.J. Brown Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor Mol. Cell Endocrinol. 126 1997 59 73
18. J.S. Horoszewicz, S.S. Leong, T.M. Chu, Z.L. Wajsman, M. Friedman, L. Papsidero, U. Kim, L.S. Chai, S. Kakati, S.K. Arya, and A.A. Sandberg The LNCaP cell line-a new model for studies on human prostatic carcinoma Prog. Clin. Biol. Res. 37 1980 115 132
19. J.S. Horoszewicz, S.S. Leong, E. Kawinski, J.P. Karr, H. Rosenthal, T.M. Chu, E.A. Mirand, and G.P. Murphy LNCaP model of human prostatic carcinoma Cancer Res. 43 1983 1809 1818
20. H. Huang, and D.J. Tindall The role of the androgen receptor in prostate cancer Crit. Rev. Eukaryot. Gene Expr. 12 2002 193 207
21. F. Kaspar, H. Klocker, A. Denninger, and A.C. Cato A mutant androgen receptor from patients with reifenstein syndrome: identification of the function of a conserved alanine residue in the D box of steroid receptors Mol. Cell Biol. 13 1993 7850 7858
22. W.R. Kelce, L.E. Gray, and E.M. Wilson Antiandrogens as environmental endocrine disruptors Reprod. Fertil. Dev. 10 1998 105 111
23. W.R. Kelce, C.R. Stone, S.C. Laws, L.E. Gray, J.A. Kemppainen, and E.M. Wilson Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist Nature 375 1995 581 585
24. W.R. Kelce, and E.M. Wilson Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications J. Mol. Med. 75 1997 198 207
25. H.K. Kinyamu, C.J. Fryer, K.B. Horwitz, and T.K. Archer The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor J. Biol. Chem. 275 2000 20061 20068
26. R. Kizu, N. Otsuki, Y. Kishida, A. Toriba, A. Mizokami, K.L. Burnstein, C.M. Klinge, and K. Hayakawai A new luciferase reporter gene assay for the detection of androgenic and antiandrogenic effects based on a human prostate specific antigen promoter and PC3/AR human prostate cancer cells Anal. Sci. 20 2004 55 59
27. M. Maggiolini, A. Vivacqua, A. Carpino, D. Bonofiglio, G. Fasanella, M. Salerno, D. Picard, and S. Andó The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells Mol. Pharmacol. 62 2002 1027 1035
28. N.J. McKenna, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators: cellular and molecular biology Endocrine Rev. 20 1999 321 344
29. M.J. McPhaul Molecular defects of the androgen receptor Recent Prog. Horm. Res. 57 2002 181 194
30. S.O. Mueller Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens J. Chromatogr. 777 2002 155 165
31. B.A. Narayanan, N.K. Narayanan, G.G. Re, and D.W. Nixon Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets Int. J. Cancer 104 2003 204 212
32. F. Neumann, and M. Topert Pharmacology of antiandrogens J. Steroid Biochem. 25 1986 885 895
33. P.S. Rennie, N. Bruchovsky, J. Leco, and P. Sheppard Characterization of two cis-acting dna elements involved in the androgen regulation of the probasin gene Mol. Endocrinol. 7 1993 23 36
34. P.J. Roche, S.A. Hoare, and M.G. Parker A consensus DNA-binding site for the androgen receptor Mol. Endocrinol. 6 1992 2229 2235
35. P. Sohoni, and J.P. Sumpter Several environmental oestrogens are also anti-androgens J. Endocrinol. 158 1998 327 339
36. R.M. Sramkoski A new human prostate carcinima cell line, 22Rv1 In Vitro Cell Dev. Biol. Anim. 35 1999 403 409
37. C. Sultan, P. Balaguer, B. Terouanne, V. Georget, F. Paris, C. Jeandel, S. Lumbroso, and J. Nicolas Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation Mol. Cell Endocrinol. 178 2001 99 105
38. C.G. Tepper, D.L. Boucher, P.E. Ryan, A.H. Ma, L. Xia, L.F. Lee, T.G. Pretlow, and H.J. Kung Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line Cancer Res. 62 2002 6606 6614
39. M. Truss, and M. Beato Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors Endocr. Rev. 14 1993 459 479
40. A. van Bokhoven, M. Varella-Garcia, C. Korch, W.U. Johannes, E.E. Smith, H.L. Miller, S.K. Nordeen, G.J. Miller, and M.S. Lucia Molecular characterization of human prostate carcinoma cell lines Prostate 57 2003 205 225
41. J. Veldscholte, C.A. Berrevoets, A.O. Brinkmann, J.A. Grootegoed, and E. Mulder Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation Biochemistry 31 1992 2393 2399
42. J. Veldscholte, C. Ris Stalpers, G.G. Kuiper, G. Jenster, C. Berrevoets, E. Claassen, H.C. van Rooij, J. Trapman, A.O. Brinkmann, and E. Mulder A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens Biochem. Biophys. Res. Commun. 173 1990 534 540
43. G. Verrijdt, E. Schoenmakers, P. Alen, A. Haelens, B. Peeters, W. Rombauts, and F. Claessens Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element Mol. Endocrinol. 13 1 1999 558 1570
44. A.M. Vinggaard, E.C. Joergensen, and J.C. Larsen Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals Toxicol. Appl. Pharmacol. 155 1999 150 160
45. Whitaker, H.C., Hanrahan, S., Totty, N., Gamble, S.C., Waxman, J., Cato, A.C., Hurst, H.C., Bevan, C.L., 2004. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens. Clin. Cancer Res. 10, 7392-7401.
46. V.S. Wilson, K. Bobseine, C.R. Lambright, and L.E. Gray Jr. A novel cell line, MDA-kb2. That stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists Toxicol. Sci. 66 2002 69 81
47. S. Yeh, H. Miyamoto, H. Shima, and C. Chang From estrogen to androgen receptor: a new pathway for sex hormones in prostate Proc. Natl. Acad. Sci. U.S.A. 95 1998 5527 5532
48. Z. Zhou, J.L. Corden, and T.R. Brown Identification and characterization of a novel androgen response element composed of a direct repeat J. Biol. Chem. 272 1997 8227 8235